CY1115622T1 - Εστερες μετρονιδαζολης για αντιμετωπιση ροδοχρου ακμης - Google Patents

Εστερες μετρονιδαζολης για αντιμετωπιση ροδοχρου ακμης

Info

Publication number
CY1115622T1
CY1115622T1 CY20141100831T CY141100831T CY1115622T1 CY 1115622 T1 CY1115622 T1 CY 1115622T1 CY 20141100831 T CY20141100831 T CY 20141100831T CY 141100831 T CY141100831 T CY 141100831T CY 1115622 T1 CY1115622 T1 CY 1115622T1
Authority
CY
Cyprus
Prior art keywords
metronidazol
estes
acme
rose
treatment
Prior art date
Application number
CY20141100831T
Other languages
English (en)
Inventor
Jean-Guy Boiteau
Jean-Michel Linget
Original Assignee
Galderma Research & Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research & Development filed Critical Galderma Research & Development
Publication of CY1115622T1 publication Critical patent/CY1115622T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μία ένωση επιλεγμένη από την ένωση του τύπου (Ι) παρακάτω· εναντιομερή αυτής και φαρμακευτικώς αποδεκτά άλατα αυτής, και επίσης με τις χρήσεις αυτής.
CY20141100831T 2010-06-29 2014-10-13 Εστερες μετρονιδαζολης για αντιμετωπιση ροδοχρου ακμης CY1115622T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1055241A FR2961809B1 (fr) 2010-06-29 2010-06-29 Esters de metronidazole pour traiter la rosacee
EP11729972.7A EP2588462B1 (en) 2010-06-29 2011-06-29 Metronidazole esters for treating rosacea

Publications (1)

Publication Number Publication Date
CY1115622T1 true CY1115622T1 (el) 2017-01-04

Family

ID=42790955

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100831T CY1115622T1 (el) 2010-06-29 2014-10-13 Εστερες μετρονιδαζολης για αντιμετωπιση ροδοχρου ακμης

Country Status (23)

Country Link
US (1) US8802710B2 (el)
EP (1) EP2588462B1 (el)
JP (1) JP2013529667A (el)
KR (1) KR20130088135A (el)
CN (1) CN102958920A (el)
AR (1) AR081783A1 (el)
AU (1) AU2011273498A1 (el)
BR (1) BR112012032490A2 (el)
CA (1) CA2801977A1 (el)
CY (1) CY1115622T1 (el)
DK (1) DK2588462T3 (el)
ES (1) ES2518119T3 (el)
FR (1) FR2961809B1 (el)
HR (1) HRP20140966T1 (el)
IN (1) IN2013CN00515A (el)
MX (1) MX2012014632A (el)
PL (1) PL2588462T3 (el)
PT (1) PT2588462E (el)
RS (1) RS53623B1 (el)
RU (1) RU2013103693A (el)
SI (1) SI2588462T1 (el)
SM (1) SMT201400174B (el)
WO (1) WO2012001053A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9715942B2 (en) 2015-06-09 2017-07-25 International Business Machines Corporation Built-in self-test (BIST) circuit and associated BIST method for embedded memories

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127274A3 (en) * 1983-03-25 1987-05-20 The Upjohn Company Esters of metronidazole and compositions containing them
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US8853247B2 (en) * 2007-11-02 2014-10-07 Nektar Therapeutics Oligomer-nitroimidazole anti-infective conjugates

Also Published As

Publication number Publication date
MX2012014632A (es) 2013-02-07
PT2588462E (pt) 2014-10-30
US8802710B2 (en) 2014-08-12
KR20130088135A (ko) 2013-08-07
US20130217740A1 (en) 2013-08-22
RS53623B1 (en) 2015-04-30
CN102958920A (zh) 2013-03-06
AU2011273498A1 (en) 2013-01-10
RU2013103693A (ru) 2014-08-10
SMT201400174B (it) 2015-01-15
EP2588462A1 (en) 2013-05-08
CA2801977A1 (en) 2012-01-05
BR112012032490A2 (pt) 2016-12-13
EP2588462B1 (en) 2014-08-13
PL2588462T3 (pl) 2015-03-31
WO2012001053A1 (en) 2012-01-05
IN2013CN00515A (el) 2015-07-03
HRP20140966T1 (hr) 2015-01-02
ES2518119T3 (es) 2014-11-04
DK2588462T3 (da) 2014-11-03
FR2961809A1 (fr) 2011-12-30
FR2961809B1 (fr) 2012-07-06
AR081783A1 (es) 2012-10-17
JP2013529667A (ja) 2013-07-22
SI2588462T1 (sl) 2015-02-27

Similar Documents

Publication Publication Date Title
CY1118478T1 (el) Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
CY1118093T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt
EA201290632A1 (ru) Производные бетулина
EA201590200A1 (ru) Модуляторы пути активации комплемента и их применение
EA201691085A1 (ru) Замещенные бензамиды и способы их применения
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
EA201270216A1 (ru) Фармацевтический состав
CY1123056T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
PE20150887A1 (es) Compuestos de benceno sustituidos
UA110338C2 (en) Chemical compounds
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
EA201590296A1 (ru) Дейтерированный ибрутиниб
EA201590951A1 (ru) Дигидропиразольные модуляторы gpr40
EA201300388A1 (ru) Соединения замещенного бензамида
EA201590954A1 (ru) Дигидропиразольные модуляторы gpr40
EA201590949A1 (ru) Дигидропиразольные модуляторы gpr40
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
UA113086C2 (xx) Піразольні сполуки як інгібітори sglt1
CY1118585T1 (el) Ενωση βενζοθειαζολονης
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу